SEC Form 4 · accession 0001179110-17-001198
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Dresner
Officer — Interim President & CEO
Period of report
Jan 23, 2017
Accepted (ET)
Jan 24, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2017 | M | 5,000 | $5.03 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $5.03 | Jan 23, 2017 | M | 5,000 | D | Jul 11, 2016 | Dec 31, 2017 | Common Stock | 5,000 | 15,000 | D |